Title : Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia.

Pub. Date : 2020 Jan 15

PMID : 31952182






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Although tyrosine kinase inhibitors (TKIs) against BCR-ABL represent the standard therapeutic option for CML, resistances to TKIs can be a serious problem. Tyrosine ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens